title: Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
abstract: The majority of immunogenic CTL epitopes bind to MHC class I molecules with high affinity. However, peptides longer or shorter than the optimal epitope rarely bind with high affinity. Therefore, identification of optimal CTL epitopes from pathogens may ultimately be critical for inducing strong CTL responses and developing epitope-based vaccines. The SIV-infected rhesus macaque is an excellent animal model for HIV infection of humans. Although a number of CTL epitopes have been mapped in SIV-infected rhesus macaques, the optimal epitopes have not been well defined, and their anchor residues are unknown. We have now defined the optimal SIV gag CTL epitope restricted by the rhesus MHC class I molecule Mamu-A*01 and defined a general peptide binding motif for this molecule that is characterized by a dominant position 3 anchor (proline). We used peptide elution and sequencing, peptide binding assays, and bulk and clonal CTL assays to demonstrate that the optimal Mamu-A*01-restricted SIV gag CTL epitope was CTPYDINQM(181-189). Mamu-A*01 is unique in that it is found at a high frequency in rhesus macaques, and all SIV-infected Mamu-A*01-positive rhesus macaques studied to date develop an immunodominant gag-specific CTL response restricted by this molecule. Identification of the optimal SIV gag CTL epitope will be critical for a variety of studies designed to induce CD8+ CTL responses specific for SIV in the rhesus macaque.
authors.affiliation: Wisconsin Regional Primate Research Center, University of Wisconsin, Madison 53715, USA.
authors.forename: T M
authors.initials: TM
authors.lastname: Allen
authors.forename: J
authors.initials: J
authors.lastname: Sidney
authors.forename: M F
authors.initials: MF
authors.lastname: del Guercio
authors.forename: R L
authors.initials: RL
authors.lastname: Glickman
authors.forename: G L
authors.initials: GL
authors.lastname: Lensmeyer
authors.forename: D A
authors.initials: DA
authors.lastname: Wiebe
authors.forename: R
authors.initials: R
authors.lastname: DeMars
authors.forename: C D
authors.initials: CD
authors.lastname: Pauza
authors.forename: R P
authors.initials: RP
authors.lastname: Johnson
authors.forename: A
authors.initials: A
authors.lastname: Sette
authors.forename: D I
authors.initials: DI
authors.lastname: Watkins
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D018604:Epitope Mapping; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D008253:Macaca mulatta; D011392:Proline / Q000378:metabolism; D011485:Protein Binding; D015302:Simian Immunodeficiency Virus / Q000276:immunology*
chemical_list: D018984:Epitopes, T-Lymphocyte; D015395:Histocompatibility Antigens Class I; C110764:Mamu-A 01 antigen; D011392:Proline